Lattice Biologics upgrades to OTCQB Venture Market
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Lattice Biologics Inc. got approval to upgrade its common shares to the OTCQB Venture Market from the Pink Open Market, effective Jan. 31.
Company shares on the OTCQB will trade under the ticker symbol LBLTF.